PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2022.01552022283473-477Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?Qian Jin, Rui-Xu Yang, Jian-Gao Fanhttp://e-cmh.org/upload/pdf/cmh-2022-0155.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0155, http://e-cmh.org/upload/pdf/cmh-2022-0155.pdf
Yearbook of Pathology and Laboratory Medicine10.1016/s1077-9108(09)79265-52010201044-45Does Nonalcoholic Fatty Liver Disease Predispose Patients to Hepatocellular Carcinoma in the Absence of Cirrhosis?P.A. Bejaranohttps://api.elsevier.com/content/article/PII:S1077910809792655?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1077910809792655?httpAccept=text/plain
Clinical Liver Disease10.1002/cld.66201214129-130Management of nonalcoholic fatty liver disease in childrenJean P. Mollestonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.66, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.66/fullpdf
Clínica e Investigación en Arteriosclerosis (English Edition)10.1016/j.artere.2017.07.0012017294185-200Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver diseaseÁngel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botethttps://api.elsevier.com/content/article/PII:S2529912317000432?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2529912317000432?httpAccept=text/plain
Journal of Clinical Lipidology10.1016/j.jacl.2017.04.1152017114915-919Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcomeSabry M. Abdeldyem, Tarek Goda, Samy A. Khodeir, Sabry Abou Saif, Sherief Abd-Elsalamhttps://api.elsevier.com/content/article/PII:S1933287417302532?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1933287417302532?httpAccept=text/plain
Clinical Liver Disease10.1002/cld.65201214104-107Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkersMazen Noureddin, Rohit Loombahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.65, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.65/fullpdf
Clínica e Investigación en Arteriosclerosis (English Edition)10.1016/j.artere.2016.06.0012017293141-148Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (i). Nonalcoholic fatty liver disease and its association with cardiovascular diseaseÁngel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botethttps://api.elsevier.com/content/article/PII:S2529912317000304?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2529912317000304?httpAccept=text/plain
Nonalcoholic Fatty Liver Disease - An Update10.5772/intechopen.880412019Introductory Chapter: Nonalcoholic Fatty Liver Disease - What Should We Know?Emad Hamdy Gad, Yasmin Kamelhttp://www.intechopen.com/download/pdf/68011
Nonalcoholic Fatty Liver Disease - An Update10.5772/intechopen.857802019The Rise in the Prevalence of Nonalcoholic Fatty Liver Disease and Hepatocellular CarcinomaZaki A. Sherifhttp://www.intechopen.com/download/pdf/68253
Clinical Liver Disease10.1002/cld.27201214112-113Natural history of nonalcoholic fatty liver diseaseRohini Mehta, Zobair M. Younossihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.27, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.27/fullpdf